66 95

Detection of Phenolic Glycolipid I of Mycobacterium leprae in Sera from Leprosy Patients before and after Start of Multidrug Therapy

Authors
 Sang-Nae Cho  ;  Roland V. Cellona  ;  Laarni G. Villahermosa  ;  Tranquilino T. Fajardo, Jr.  ;  M. Victoria F. Balagon  ;  Rodolfo M. Abalos  ;  Esterlina V. Tan  ;  Gerald P. Walsh  ;  Joo-Deuk Kim  ;  Patrick J. Brennan 
Citation
 Clinical and Diagnostic Laboratory Immunology, Vol.8(1) : 138-142, 2001 
Journal Title
 Clinical and Diagnostic Laboratory Immunology 
ISSN
 1071-412X 
Issue Date
2001
Abstract
A total of 100 untreated new leprosy patients were recruited prospectively and examined for the presence of phenolic glycolipid I (PGL-I) antigen in their serum specimens by dot enzyme-linked immunosorbent assay (ELISA) using rabbit anti-PGL-I antiserum. The presence of circulating PGL-I antigen was closely related to the bacterial indices (BI) of the patients. The PGL-I antigen was detectable in 27 (93.1%) of 29 patients with a BI of 4.0 or above and in 15 (68.2%) of 22 patients with a BI of 3.0 to 3.9. However, none of the 37 patients with a BI of less than 1.9 had detectable PGL-I antigen by the methods used in this study. The level of PGL-I in serum declined rapidly by about 90% 1 month after the start of multidrug therapy. This study showed clearly that anti-PGL-I IgM antibodies and circulating PGL-I antigen levels reflect the bacterial loads in untreated leprosy patients. The serological parameters based on the PGL-I antigen may therefore be useful in the assessment of leprosy patients at the time of diagnosis and possibly in monitoring patients following chemotherapy.
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/142844
Files in This Item:
T200103143.pdf Download
DOI
10.1128/CDLI.8.1.138-142.2001
Appears in Collections:
1. Journal Papers (연구논문) > 1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실)
Yonsei Authors
조상래(Cho, Sang Nae)
Export
RIS (EndNote)
XLS (Excel)
XML
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse